ClearPoint Neuro director granted 12,820 RSUs
FLETCHER R JOHN reported acquisition or exercise transactions in this Form 4 filing.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
FLETCHER R JOHN reported acquisition or exercise transactions in this Form 4 filing.
ClearPoint Neuro, Inc. director R John Fletcher received a grant of 12,820 restricted stock units as equity compensation. Each unit represents a contingent right to one share of CLPT common stock. The units vest on the earlier of the first anniversary of the grant date or the day immediately before the company’s 2027 annual meeting of stockholders. Following this award, Fletcher holds 12,820 RSUs directly.
Insider Trade Summary
Grant/Award: 12,820 shares
Grant/Award
1 txn
Insider
FLETCHER R JOHN
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Units | 12,820 | $0.00 | $0.00 |
Holdings After Transaction:
Restricted Stock Units — 12,820 contracts (Direct)
Holdings Before and After:
Restricted Stock Units, 0 to 12,820 contracts (Direct)
Footnotes (2)
- F1. Each restricted stock unit represents a contingent right to receive one share of CLPT common stock.
- F2. The restricted stock units vest on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2027 annual meeting of stockholders.
Key Figures
RSUs granted: 12,820 units
Grant price per RSU: $0.00 per unit
Underlying common shares: 12,820 shares
+1 more
4 metrics
RSUs granted
12,820 units
Restricted stock unit award to director on May 21, 2026
Grant price per RSU
$0.00 per unit
Equity compensation award, no cash paid by insider
Underlying common shares
12,820 shares
Each RSU represents one share of CLPT common stock
RSUs held after grant
12,820 units
Total restricted stock units directly owned post-transaction
Key Terms
Restricted Stock Units, contingent right, vest, annual meeting of stockholders
4 terms
Restricted Stock Units financial
"Each restricted stock unit represents a contingent right to receive one share of CLPT common stock."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
contingent right financial
"Each restricted stock unit represents a contingent right to receive one share of CLPT common stock."
vest financial
"The restricted stock units vest on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2027 annual meeting of stockholders."
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
annual meeting of stockholders financial
"The restricted stock units vest on the earlier of ... the day immediately preceding the Company's 2027 annual meeting of stockholders."
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did ClearPoint Neuro (CLPT) report for R John Fletcher?
ClearPoint Neuro reported that director R John Fletcher received a grant of 12,820 restricted stock units as equity compensation. These units are not a market purchase or sale but an award from the company tied to future vesting conditions.
How many restricted stock units did the ClearPoint Neuro director receive?
R John Fletcher received 12,820 restricted stock units from ClearPoint Neuro. Each unit represents a contingent right to one share of CLPT common stock, subject to vesting conditions based on time and the timing of the company’s 2027 annual meeting of stockholders.
When do the new ClearPoint Neuro RSUs granted to R John Fletcher vest?
The restricted stock units vest on the earlier of the first anniversary of the grant date or the day immediately preceding ClearPoint Neuro’s 2027 annual meeting of stockholders. This time-based vesting schedule ties Fletcher’s equity award to continued board service over the period.
Is the ClearPoint Neuro Form 4 transaction a stock purchase or sale?
The Form 4 reports a grant of restricted stock units, not an open-market purchase or sale. Fletcher acquired 12,820 RSUs as compensation at a price of $0.00 per unit, reflecting an award rather than a cash transaction in the company’s common stock.
How many ClearPoint Neuro RSUs does R John Fletcher hold after this grant?
After this grant, R John Fletcher holds 12,820 restricted stock units directly. These RSUs each represent a contingent right to receive one share of ClearPoint Neuro common stock, subject to the specified vesting schedule tied to time and the 2027 annual meeting.
AI-generated analysis. How Rhea-AI works. Not financial advice.
